IPD ImpediMed Limited
—Mkt Cap: —P/E: —1d ago
ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value16.09M USD
Revenue (TTM)10.10M USD
Gross Profit8.83M USD
Net Income (TTM)-17.21M USD
Revenue/Share0.0070 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees66
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000IPD8
Valuation
P/E (Trailing)—
P/E (Forward)-3.24
PEG—
EV/EBITDA-1.10
EV/Revenue1.59
P/S1.50
P/B2.00
EPS (TTM)-0.01
EPS (Forward)-0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin87.39%
Oper. Margin-146.22%
EBITDA Margin-144.63%
Profit Margin-170.44%
ROE-244.50%
ROA-71.86%
Growth
Revenue Growth5.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.34M USD
CapEx (TTM)878.37K USD
FCF Margin-97.45%
FCF Yield—
Net Debt905.32K USD
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity1.63
Current Ratio3.81
Quick Ratio3.23
Book Value/Sh0.0030 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.0209 AUD
Target Range0.0086 AUD – 0.0400 AUD
# Analysts4
Ownership
Shares Out.3.66B
Float3.21B
Insiders9.20%
Institutions21.05%
Technical
SMA 500.0053 AUD
SMA 2000.0116 AUD
Beta1.07
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)6.01M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—